Comparison of Allegra vs Sapien Transcatheter Aortic Valves in Valve-In-Valve Indication
NCT: NCT06049654 · RECRUITING
Brief Summary
The VIVALL-2 study is a randomized trial to compare the self-expandable supra-annular Allegra and the balloon-expandable intra-annular Edwards transcatheter valve systems in patients with degenerated biological aortic surgical valve.
Frequently Asked Questions
What is Comparison of Allegra vs Sapien Transcatheter Aortic Valves in Valve-In-Valve Indication?
Comparison of Allegra vs Sapien Transcatheter Aortic Valves in Valve-In-Valve Indication is a clinical trial registered under NCT06049654. Current status: RECRUITING.
What is the status of NCT06049654?
The current status of NCT06049654 (Comparison of Allegra vs Sapien Transcatheter Aortic Valves in Valve-In-Valve Indication) is: RECRUITING.
When did Comparison of Allegra vs Sapien Transcatheter Aortic Valves in Valve-In-Valve Indication start?
Comparison of Allegra vs Sapien Transcatheter Aortic Valves in Valve-In-Valve Indication started on 2024-02-01.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.